Genus (LON:GNS – Get Free Report) had its price target lifted by research analysts at Deutsche Bank Aktiengesellschaft from GBX 2,250 ($30.19) to GBX 2,550 ($34.22) in a research report issued on Tuesday, MarketBeat.com reports. The firm currently has a “buy” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target points to a potential upside of 6.92% from the company’s current price.
Separately, Shore Capital reaffirmed a “buy” rating and set a GBX 2,750 ($36.90) target price on shares of Genus in a report on Tuesday.
Read Our Latest Research Report on Genus
Genus Stock Performance
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.
Further Reading
- Five stocks we like better than Genus
- Profitably Trade Stocks at 52-Week Highs
- 3 Stocks to Cushion Your Portfolio This Earnings Season
- Asset Allocation Strategies in Volatile Markets
- This Fund Manager Says You Should Get Out of Tesla and Apple—Now
- Overbought Stocks Explained: Should You Trade Them?
- JNJ’s Stock Price Is Back in Rally Mode—The Time to Buy Is Now
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.